What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

Ivan Gentile; Alberto Enrico Maraolo; Guglielmo Borgia

doi:10.1080/14787210.2016.1233060

What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

Expert Rev Anti Infect Ther. 2016 Oct;14(10):875-8. doi: 10.1080/14787210.2016.1233060.

Authors

Ivan Gentile¹, Alberto Enrico Maraolo¹, Guglielmo Borgia¹

Affiliation

¹ a Section of Infectious Diseases, Department of Clinical Medicine and Surgery , University of Naples 'Federico II' , Naples , Italy.

PMID: 27599088
DOI: 10.1080/14787210.2016.1233060

No abstract available

Keywords: Ceftolozane/tazobactam; Enterobacteriaceae; Pseudomonas aeruginosa; carbapenem-sparing regimens; ceftazidime/avibactam; complicated intra-abdominal infections; complicated urinary tract infections; multidrug-resistance.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Azabicyclo Compounds / therapeutic use*
Ceftazidime / therapeutic use*
Cephalosporins / therapeutic use*
Drug Combinations
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae Infections / drug therapy*
Humans
Intraabdominal Infections / drug therapy*
Penicillanic Acid / analogs & derivatives*
Penicillanic Acid / therapeutic use
Pseudomonas Infections / drug therapy*
Tazobactam
Urinary Tract Infections / drug therapy*
beta-Lactamase Inhibitors / therapeutic use
beta-Lactams / therapeutic use

Substances

Anti-Bacterial Agents
Azabicyclo Compounds
Cephalosporins
Drug Combinations
avibactam, ceftazidime drug combination
beta-Lactamase Inhibitors
beta-Lactams
ceftolozane, tazobactam drug combination
Penicillanic Acid
Ceftazidime
Tazobactam